What is IHMA?
IHMA stands as a premier global microbiology service provider, dedicated to supporting the biopharmaceutical industry. The company leverages its deep laboratory expertise and industry knowledge to facilitate efficient and effective anti-infective product discovery and development. IHMA's services are crucial for developing diagnostic devices that can detect bacterial resistance to antimicrobial agents and for tracking emerging technologies in this critical field.
How much funding has IHMA raised?
IHMA has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in IHMA
PPP
Public-Private Partnership
What's next for IHMA?
The recent major strategic investment signals a new phase of growth and innovation for IHMA. This capital infusion is expected to accelerate the company's research and development initiatives, potentially expanding its service offerings and market reach. IHMA is well-positioned to capitalize on the increasing demand for advanced microbiology services, particularly in the fight against antimicrobial resistance and the development of novel therapeutics.
See full IHMA company page
